ViCentra Strengthens Leadership Team to Accelerate Growth
ViCentra, a European medical device company, announced two strategic senior leadership appointments following the company’s recent $85 million Series D financing.
Karen Baxter, former VP & GM at Dexcom, joins as SVP Sales, Europe, bringing deep expertise in diabetes device commercialization across Europe.
Jay Little, a leader from Medtronic Diabetes, is appointed VP Strategy & Business Development, to drive growth strategy and market development.
- Karen Baxter: SVP Sales, Europe, former VP & GM at Dexcom
- Jay Little: VP Strategy & Business Development, former leader at Medtronic Diabetes
Team expansion will drive growth strategy, market development
Author's summary: ViCentra expands leadership team.
More News
- Founding partner Microsoft to bring new Discovery AI technology to NJ AI Hub
- Football defeats Bates on homecoming weekend - The Middlebury Campus
- Meet ... Dr Rose Karimi Kiwanuka, director, ICA Africa
- How I processed grief at Middlebury - The Middlebury Campus
- Proton Data Breach Observatory aims to alert you in near real-time
- AirAsia parent Capital A revives Nasdaq IPO plan for subsidiary
- A Difference of Opinion Editors: Interrogating the ethics of self-plagiarism in academia - Daily Bruin
- Student death remains the routine at Middlebury - The Middlebury Campus
- Fashion lovers step out for Carol Byrne X Very Partywear Edit
- The reverent, subversive Gilead